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T cell protective immunity is associated with multifunctional memory cells that produce
several different cytokines. Currently, our understanding of when and how these cells are
generated is limited. We have used an influenza virus mouse infection model to inves-
tigate whether the cytokine profile of memory T cells is reflective of primary respond-
ing cells or skewed toward a distinct profile. We found that, in comparison to primary
cells, memory T cells tended to make multiple cytokines simultaneously. Analysis of the
timings of release of cytokine by influenza virus-specific T cells, demonstrated that pri-
mary responding CD4 T cells from lymphoid organs were unable to produce a sustained
cytokine response. In contrast CD8 T cells, memory CD4 T cells, and primary respond-
ing CD4 T cells from the lung produced a sustained cytokine response throughout the
restimulation period. Moreover, memory CD4 T cells were more resistant than primary
responding CD4 T cells to inhibitors that suppress T cell receptor signaling. Together,
these data suggest that memory CD4 T cells display superior cytokine responses com-
pared to primary responding cells. These data are key to our ability to identify the cues
that drive the generation of protective memory CD4 T cells following infection.
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Introduction
Immunological memory provides superior immune protection
from pathogens for two reasons. First, there are more pathogen-
specific cells present in the memory as compared to the na¨ıve com-
partment. Second, memory cells are intrinsically different from
na¨ıve cells: they are located in peripheral organs as well as in sec-
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ondary lymphoid organs; are more sensitive to activation signals;
and provide a more tailored response [1, 2].
This tailored response is defined by the effector cytokines
T cells express and is one of the main mechanisms of T cell-
mediated immune protection. The ability to track antigen-specific
T cells via their cytokine profile is essential to understand their
protective potential. This cytokine profile is shaped by pathogen-
triggered signals during the primary response [3]. These signals
drive the effector cytokine production, such as IFN-γ, IL-4, or
IL-17, most effective at coordinating pathogen control [2, 4].
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Multiple studies demonstrate that memory T cells can develop
from differentiated, effector cytokine producing cells [5–8]. How-
ever, there is also evidence that the least differentiated cells are
more likely to enter the memory pool suggesting that these cells
may dominate the memory pool [9–11]. Such cells may not, how-
ever, offer the best protection. The most effective memory T cells
are thought to be cells that produce high levels of a range of dif-
ferent cytokines, termed poly or multifunctional T cells [12–15].
While it is not yet clear why multifunctional memory T cells offer
the most effective protection, their ability to produce cytokines,
such as IFN-γ, that activate innate immune cells and IL-2, which
aids T-cell proliferation, means they both drive and sustain sec-
ondary responses.
Understanding the relationship between primary responding
and memory T cells will aid in the design of vaccines that aim
to drive protective immunological memory. A major hurdle in
characterizing pathogen-specific T cells is in their identification.
Most studies use either monoclonal TCR transgenic CD4 T cells or
identify endogenous T cells specific to a single epitope [16–20].
This narrow focus limits the research scope, especially as CD4
T cells are thought to respond to a diverse range of pathogen
epitopes [21, 22].
Here, we address how the cytokine profile of endogenous poly-
clonal pathogen-specific effector CD4 and CD8 T cells relates to
that of subsequently generated memory T cells. We find that, in
comparison to primary effector T cells, memory CD4 T cells have
an increased tendency to be multifunctional, display a more sus-
tained cytokine response, and are less sensitive to inhibitors of
TCR signaling. Memory CD8 T cells are also more likely to be mul-
tifunctional than primary responding cells. However, primary and
memory CD8 T cells are similar in the sustainability of the cytokine
response and their sensitivity to TCR signaling inhibitors.
Results
Cytokine producing CD4 T cells decline most
dramatically in the lung
The primary immune response is usually followed by a contrac-
tion phase in which most activated T cells undergo cell death
[23]. Highly differentiated effector cytokine producing T cells are
thought to be more likely to undergo apoptosis than less differenti-
ated IL-2-producing cells [18]. Moreover, memory cells in periph-
eral tissue are thought to be more differentiated than those in
lymphoid organs and the bone marrow has been proposed as a
site of memory T cell maintenance [24–29].
To address these assumptions, we examined the ex vivo
cytokine responses of CD4 and CD8 T cells isolated from mice
infected with influenza A virus (IAV) at the peak of the pri-
mary responses, day 9, and at two memory time points, days
30 and 75. We identified IAV-specific T cells by their ability
to produce cytokine, following ex vivo restimulation with bone
marrow-derived dendritic cells (bmDCs) incubated overnight with
IAV. Incubation of bmDCs with IAV (IAV+ bmDCs) caused minor
upregulation of MHC II and costimulatory molecules (Supporting
Information Fig. 1).
In all organs, we identified populations of IFN-γ, TNF-α, and
IL-2 IAV-specific T cells (Supporting Information Figs. 2 and 3).
Overall, the number of cytokine+ IAV-specific CD4 T cells declined
from the peak response at day 9 and then numbers levelled out
(Fig. 1A). The decline in numbers of cytokine producing CD4
T cells was most obvious in the lung for IFN-γ+ cells and least
obvious in the bone marrow for TNF-α and IL-2+ cells, although
this organ contained the smallest numbers of cytokine+ cells. Sim-
ilarly, IAV-specific CD8 T cells declined from day 9 to day 30,
although the small number of IL-2+ cells remained fairly constant.
After the contraction phase, the numbers of cytokine+ CD8 T cells
largely remained steady. For CD4 T cells, the memory cells were
predominantly found in the spleen and mediastinal lymph node,
while CD8 cytokine+ T cells were mainly found in the spleen.
The dramatic decrease of T cells in the lung could have been
due to a large population of IAV-specific T cells within the lung
vasculature at day 9. However, by labelling these cells in vivo
with fluorescently labelled anti-CD45 shortly before the tissues
were harvested [30], we found that more IAV-specific cytokine+
T cells were found in the blood at memory as compared to primary
time points (Fig. 1B).
Together these data confirm that, as expected, cytokine+
T cells contract from the peak of disease. However, our data sug-
gest that cytokine+ memory T cells in lymphoid organs are just as
likely as those from peripheral tissues to make effector cytokines.
We did not observe preferential survival of memory CD4 or CD8
T cells in the bone marrow and, given the small numbers of mem-
ory CD4 T cells present in the bone marrow did not pursue these
cells further.
Memory T cells are more likely to be multifunctional
than primary responding T cells
Given that IL-2, particularly autocrine IL-2, is thought to support
memory T-cell development [18], we expected to see an increased
proportion of IL-2 producing T cells in the memory pool. We did
not observe a dramatic shift toward IL-2+ IAV-specific CD4 T cells
within the memory pool (Fig. 1). Rather, similar numbers of IAV-
specific cells identified by any one of the three cytokines sug-
gested that these may be the same cells that produce all three
cytokines. To address this, we examined the combined cytokine
producing capacity of individual cells in both the primary and
memory response.
For CD4 T cells, we observed a consistent increase in the pro-
portion of multifunctional cytokine+ cells that produced IFN-γ,
TNF-α, and IL-2 in all three organs examined (Fig. 2). This shift
was associated with a reduction in single IFN-γ+ cells. At day 9,
minimal IL-2 was made by CD8 T cells. However, memory CD8
T cells are more likely to make IL-2 than primary responding
cells [11, 31, 32]. We confirmed this and found that, as with the
CD4 T cell response, the memory CD8 T cell pool was more likely
to contain multifunctional CD8 T cells.
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Figure 1. Cytokine producing IAV-specific memory CD4 and CD8 T cell numbers stabilize in lymphoid organs but continue to decline in the lung.
C57BL/6 mice were infected with IAV and 9, 30, or 75 days later the IAV-specific cytokine+ T cells were examined by flow cytometry following
6 h restimulation with IAV+ bmDCs. Mice were injected with fluorescently labelled anti-CD45 shortly before tissues were harvested. In A, each
point represents the mean of 8–9 mice combined from two independent experiments; error bars are SEM and numbers are the absolute numbers
of indicated cell types present in each organ. In B, the percentages of cytokine+ CD4 and CD8 T cells that bound to the injected anti-CD45+ and
were IFN-γ+ at days 9 and 30 are shown; each point represents one mouse and the line shows the mean of the group. Data are combined from
three experiments with 3–4 mice per group.
The increase in multifunctional T cells in the memory pool
observed in the lung could have been due to the increased pro-
portion of cells in circulation rather than a shift in multifunc-
tionality in cells within the lung itself. However, for both CD4
and CD8 T cells we found similar proportions of multifunctional
cells within the i.v. injected CD45 positive and negative fractions
30 days postinfection. This demonstrates that circulating and tis-
sue resistant populations displayed similar multifunctional char-
acteristics and support the idea that memory cells, regardless of
location, shift toward increased multifunctionality (Fig. 2D and
Supporting Information Fig. 4).
The dynamics of T-cell cytokine release reveals
functional maturation of CD4, but not of CD8, T cells
To investigate the dynamics of cytokine production by T cells,
we analyzed the kinetics of cytokine secretion during the ex vivo
restimulation. T cells from mice infected with IAV 9 or 30 days
previously were activatedwith IAV+ bmDCs, andGolgi Plug added
at the start of the incubation, 2 or 4 h later. Cells were analyzed
2 h after the addition of Golgi Plug.
Primary responding and memory CD8 T cells produced sus-
tained or increased levels of cytokine, most notably IFN-γ,
throughout the restimulation period. However, primary respond-
ing CD4 T cells from lymphoid organs produced less cytokine at
4–6 h than at 2–4 h poststimulation (Fig. 3: IFN-γ and Support-
ing Information Fig. 5: TNF-α and IL-2). These data suggest that
antiviral CD4 T cells have a less sustained cytokine response than
CD8 T cells.
In contrast, lung primary responding CD4 T cells produced sus-
tained levels of cytokine suggesting that CD4 T cells from periph-
eral organs have altered regulation of their cytokine responses
compared to those from lymphoid organs (Fig. 3 and Supporting
Information Fig. 5). Interestingly, memory CD4 T cells, regard-
less of their source, displayed sustained cytokine responses with
similar percentages of cells producing cytokine throughout the res-
timulation culture. These data suggest that memory CD4 T cells
are functionally more superior than primary responding CD4
T cells.
C© 2019 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
2022 Lotus M Westerhof et al. Eur. J. Immunol. 2019. 49: 2019–2029
Figure 2. Multifunctional CD4 and CD8 T cells increase in proportion from the primary to the memory pool. Mediastinal lymph nodes, spleens,
and lungs were taken from C57BL/6 mice 9, 30, and 75 days postinfection with IAV. The percentages of IFN-γ+ CD4 and CD8 T cells that also
expressed IL-2 and/or TNF-α were determined following 6 h stimulation with IAV+ bmDCs. In A, spleen cells are gated on live CD4+ or CD8+
dump negative lymphocytes that are IFN-γ+; representative FACS plots from three experiments with three to five mice per group. In B and C data
are from two time course experiment with a total of eight to nine mice/group/time point. In D, mice infected with IAV 30 days previously were
injected i.v. with fluorescently labeled anti-CD45 3 min prior to euthanasia and lung cells stimulated and examined as in A and numbers show
mean + SD of the triple+ population. Data in D are from three experiments with a total of 10 mice. Samples were analyzed by ANOVA followed by
a Tukey’s multiple comparison test. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
An alternative explanation for this observation is that the pri-
mary responding pool contains a subset of T cells that only pro-
duce cytokine between 2 and 4 h following restimulation but that
this subset is missing from the memory pool. To investigate this,
we calculated the proportion of the number of CD4 T cells pro-
ducing IFN-γ at 2–4 h out of the number of IFN-γ+ CD4 T cells
found throughout the whole restimulation period (i.e. Golgi plug
present from 0 to 6 h). These percentages were similar between
the primary and memory CD4 T cells, regardless of which organ
was examined (Supporting Information Fig. 6). These data sug-
gest that there are similar proportions of the whole population
responding at 2–4 h in the primary and memory CD4 T cells.
By examining cytokine production across the restimulation cul-
ture, we were able to determine whether triple, double, and sin-
gle cytokine producing T cells had similar kinetics of cytokine
production. This was the case for CD4 T cells, with all popu-
lations present at the three time points examined (Fig. 3C). A
similar pattern was found for CD8 T cells, although the per-
centages of multifunctional cells in the primary response were
very low. These data show that multifunctional cells are indeed
able to produce all three cytokines simultaneously and that
these cells have similar kinetics of cytokine release as dou-
ble and single cytokine producers at primary and memory time
points.
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Figure 3. Memory CD4 T cells demonstratemore sustained cytokine production than primary responding cells. Mediastinal lymph nodes, spleens,
and lungs were taken from C57BL/6 mice 9 and 30 days postinfection with IAV and reactivated in vitro with IAV+ bmDCs for 2, 4, or 6 h in the
presence of Golgi plug for the last 2 h of culture. The percentages of IFN-γ+ CD4 (A) and CD8 T cells (B) or IFN-γ+ CD4 and CD8 T cells that also
expressed IL-2 and/or TNF-α (C) were examined at the indicated time points. Error bars show SEM. Data are combined from three experiments per
time point with four mice per time point. Samples were analyzed using a Friedman’s paired test followed by a Dunn’s multiple comparison test.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
PI3kinase inhibitors reveal altered cytokine responses
by primary responding and memory CD4 T cells
The different cytokine profiles of IAV-specific CD4 T cells between
organs and time points prompted us to investigate whether
cytokine production was regulated distinctly in these cells.
PI3Kinases (PI3K) play a key role in relating T-cell activation to
cytokine production [33]. Immune cells uniquely express two of
the four isoforms of type I PI3K: PI3K-δ, engaged by receptor tyro-
sine kinases, such as those stimulated by T or B cell receptor liga-
tion; and PI3K-γ, usually activated by G-protein coupled receptors
such as chemokine receptors [34]. These differences in signaling
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Figure 4. Memory CD4 T-cell cytokine production is less affected by PI3K inhibitors than primary responding CD4 T cells. T cells from the spleen,
Med LN, and lung were isolated from C57BL/6 mice infected with IAV either 9 or 30 days previously and reactivated with IAV+ bmDCs for 6
h in the presence of Golgi plug and the indicated PI3K inhibitor. The percentages of cytokine+ CD4 (A) and CD8 (B) T cells in each sample in
comparison to that sample’s DMSO control was calculated. Data are combined from three independent experiments at each time point with four
to five samples per experiment per time point, expect that some samples were removed from the primary responses due to lack of IL2+ cells in
the DMSO control: one sample removed from the CD4 T-cell lung analysis; one sample removed from the CD8 Med LN analysis; and two from
the lung analysis. Comparisons between cytokines within a time point were made using paired Friedman test with Dunn’s multiple comparison;
comparisons between time points were calculated using a Kruskal–Wallis with Dunn’s multiple comparison test. *p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001.
pathways predict that inhibitors that target PI3K-δ, rather than
PI3K-γ, are more likely to reduce T-cell cytokine responses.
To test the requirement for different PI3K isoforms for cytokine
production, we added PI3K inhibitors that target either PI3K-γ
or PI3K-δ to the restimulation coculture. Cytokine responses by
primary responding and memory IAV-specific CD4 and CD8 T cells
from all organs were consistently reduced by the PI3K-δ inhibitor
(Supporting Information Fig. 7). In contrast, the PI3K-γ inhibitor
had little or no effect on cytokine production.
To investigate whether the inhibitors affected the three differ-
ent cytokines distinctly and whether these were different between
primary and memory cells, we calculated the percentages of
cytokine response for each organ from each sample to that in the
relevant DMSO control (Fig. 4). For both CD4 and CD8 T cells,
IFN-γ tended to be least affected and TNF-α most likely to be
reduced for CD4 T cells and IL-2 most reduced for CD8 T cells.
Memory CD4 T cells from the spleen and lung were less sensi-
tive to the inhibitors than primary T cells. This pattern was much
less apparent for memory CD8 T cells with only IL-2 responses in
the lung and mediastinal lymph node less affected in the memory
as compared to the primary response by the P3K-γ and PI3K-δ
inhibitors, respectively.
We also examined how the inhibitors affected the proportion
of single, double, and triple cytokine producing T cells (Fig. 5).
As IFN-γ was least affected by the inhibitors, it was not surprising
that the proportion of IFN-γ single+ CD4 T cells increased in the
presence of the PI3K-δ inhibitor. This pattern was apparent in all
organs in the primary response but only slightly altered in memory
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Figure 5. Multifunctional memory CD4 T cells are less affected by PI3K inhibitors than primary responding cells. T cells from the spleen, Med
LN, and lung were isolated from C57BL/6 mice infected with IAV either 9 or 30 days previously and reactivated with IAV+ bmDCs for 6 h in the
presence of Golgi plug and the indicated PI3K inhibitor. The percentages of IFN-γ+ CD4 (A) and CD8 (B) T cells that also produced TNF-α and/or
IL-2 were examined. Data are combined from three independent experiments at each time point with four to five samples per experiment per
time point. Samples were analyzed using an ANOVA with Bonferroni’s multiple comparison test comparing each inhibitor to the DMSO control.
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
CD4 T cells from the mediastinal LN and not at all in memory CD4
T cells from the spleen and the lung.
In contrast, the effects of the inhibitors were less clearly dis-
tinct between primary and memory CD8 T cells. Triple cytokine
producing cells were slightly reduced by the PI3K-δ inhibitor in
spleen and lung in primary CD8 T cells and not at all in memory
CD8 T cells. Surprisingly, the PI3K-γ inhibitor reduced the triple
cytokine positive population in the memory T cells isolated from
the spleen and mediastinal LN. Overall, these data again high-
light the functional superiority of CD4, but not of CD8, T cell
cytokine production in the memory as compared to the primary
pool.
Discussion
Our data demonstrate that memory cytokine producing IAV-
specific CD4 T cells have distinct characteristics from the popu-
lation of activated CD4 T cells from which they are generated.
Memory CD4 T cells were much more likely to demonstrate char-
acteristics of multifunctional T cells, produced sustained cytokine
responses, and were less reliant on signals mediated by PI3Kinase-
δ to produce cytokine. Interestingly, primary responding lung CD4
T cells did display a sustained cytokine response, suggesting that
these cells may be regulated distinctly from those in lymphoid
organs.
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In contrast, while we confirm that CD8 memory T cells are
more likely to produce IL-2 [11, 31, 32], their sensitivity to PI3K
inhibitors was broadly similar to primary responding cells. More-
over, primary and memory CD8 T cells displayed similar kinetics
in their cytokine secretion with a sustained or increasing response
evident throughout the 6 h restimulation. Together, these data
show that, based on these parameters, memory CD4, but not
CD8 T cells display superior behaviors than primary responding
cells.
In all organs, we found that T cells could produce effector
cytokines, indicating that effector memory T cells were as likely
to be found in lymphoid as nonlymphoid organs. The increased
proportion of triple cytokine+ CD4 and CD8 T cells suggests that
these cells may preferentially survive. Alternatively, these cells
may mature into this phenotype following contraction, or have
improved survival over time. This last hypothesis is supported by
the continued increase in the proportion of multifunctional cells
from day 30 to day 75 in some organs. It is experimentally difficult
to discriminate between these possibilities. There are no surface
markers that discriminate between the cytokine+ populations and
neither cytokine secretion assays nor reporter mice can discrimi-
nate between single, double, and triple producers.
It is not clear why multifunctional T cells increase within
the memory pool. Potentially, the production of IL-2 provides
autocrine survival signals [18]. However, if autocrine IL-2 produc-
tion was sufficient, we would expect an increased predominance
of IL-2 single or double producing cells. This was not the case sug-
gesting that other factors, potentially working with IL-2, promote
memory T-cell generation and/or survival. Whether these factors
are directly linked to the coproduction of these three cytokines
or multifunctional cytokine production is merely a marker, is cur-
rently unclear. One potential explanation is that the repertoire
of the memory pool is skewed toward specificities that are more
likely to be multifunctional. However, there is little evidence for a
loss of breadth within the IAV CD4 T cell response from the peak
to day 60 postinfection [22].
Previous studies have compared the cytokine profiles of acti-
vated and memory CD4 T cells and found similar cytokine pro-
files between primary and memory populations [35, 36]. In these
cases, T cells in lymphoid organs were analyzed and only a single
epitope was examined. This limits the breadth of these analyses
potentially explaining differences with our data. Indeed, precursor
frequency and epitope specificity are likely to influence cytokine
response [19].
We believe analyzing a polyclonal antigen-specific population,
rather than a single epitope response, is an advantage. It is likely,
however, that our assay does not identify all responding IAV-
specific T cells as some epitopes may not be generated by the
bmDCs [37] and we are unable to identify IAV-specific T cells
that do not produce cytokine. Our data on CD8 T cells do, how-
ever, correlate with findings from studies using immunodominant
IAV epitopes [11, 31, 32]. A further caveat to our study is that
the longest time period of in vitro reactivation examined was
6 h. It will be important to examine longer reactivation periods
enabling a greater understanding of the difference between pri-
mary responding and memory T cells in terms of their ability to
produce a sustained cytokine response.
The reduced sensitivity of memory CD4 T cells to the PI3K
inhibitors and their more sustained cytokine response suggests
that these cells are less reliant on strong activation signals than
primary responding cells. This may be a consequence of increased
expression of the key signaling molecule, Zap70 [38], or altered
association of signaling molecules within lipid rafts [39]. Previ-
ous studies demonstrated reduced T cell activation and cytokine
responses in either the absence of PI3Ks or in the presence of
inhibitors [40–44]. However, in these studies, the effect of the
loss of PI3K signaling on cytokine production by CD4 T cells could
not be uncoupled from initial effects on T cell priming. In contrast,
we have directly demonstrated that inhibition of PI3K-δ reduces
TCR driven cytokine responses.
Currently, PI3K inhibitors are being tested in clinical trials for
chronic inflammatory lung diseases including chronic obstructive
pulmonary disease and asthma [45]. IAV-triggered exacerbations
are a major cause of hospitalization in these patients [46]. As IFN-
γ+ IAV-specific memory CD4 and CD8 T cells have been associated
with protection from disease following IAV infection in humans, it
is unlikely that PI3K inhibitors will interfere with protective T cell
memory [28, 47–50]. In contrast, primary virus-specific immune
responses may be more likely to be reduced by PI3K inhibitors
and the cells most likely to be affected are those most associ-
ated with immune protection, multifunctional cytokine producing
T cells. Choosing the most effective PI3K inhibitor that has the
least impact on T cell cytokine production is an important clinical
consideration. The PI3K-γ inhibitor had only a limited effect on
T cell cytokine responses suggesting it offers a good compromise.
In summary, our data demonstrate that the memory T cell pool
is not simply a mirror image of the primary response. While the
location of these two populations is similar, memory CD4 and CD8
T cells have a greater capacity tomake broader cytokine responses.
CD4 T cells were also altered in their sensitivity to TCR signaling
inhibitors and produced a more sustained cytokine response, sug-
gesting functional maturation as these cells develop into mem-
ory cells. These novel findings pave the way for an improved
understanding of the signals that regulate memory CD4 T cell
generation.
Materials and methods
Animals and infections
Ten week-old female C57BL/6 mice were purchased from Envigo
(Huntingdon,UK). They weremaintained at the University of Glas-
gow under standard animal husbandry conditions in accordance
with UK home office regulations (Project License P2F28B003)
and approved by the local ethics committee. Following 1 week of
acclimatization, the mice were briefly anesthetized using inhaled
isoflurane and infected with 200–300 plaque forming units of IAV
strain WSN in 20 μL of PBS intranasally. IAV was prepared and
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tittered in MDCK cells. Infected mice were weighed daily. Any
animals that lost more than 20% of their starting weight were
removed from the study and humanely euthanized. Group sizes
were based on previous experiments considering the known vari-
ability of the antiviral T-cell response, animals that did not lose
any weight following infection were excluded.
Tissue preparation
Where indicated, mice were injected i.v. with 1 μg of anti-CD45
(30-F11) labelled with Alexa 488 (eBioscience, Santa Clara, CA)
and euthanized by cervical dislocation 3 min later. Alternatively,
mice were euthanized with a rising concentration of carbon diox-
ide and perfused with PBS-5 mM EDTA to remove blood cells from
the lungs. Spleen and mediastinal lymph nodes were processed by
mechanical disruption. Single cell suspensions of lungs were pre-
pared by digestion with 1 mg/mL collagenase and DNAse (Sigma,
St. Louis, MI) for 40 min at 37°C. At day 30, too few cells were
recovered from the MLN for the analysis of PI3K inhibitor sensi-
tivity. Therefore, each of the organs from two mice that had lost
similar amounts of weight were combined to provide 1 day 30
sample. In the PI3K inhibitor experiments, T cells were isolated
using Stemcell mouse T-cell isolation kits following the manufac-
turer’s recommendations.
Influenza virus and control antigen
The IAV antigen was prepared using a similar protocol as descried
[51]. Briefly, T75 flasks of 80% confluent MDCK cells were incu-
bated for 1 h at 37°C, 5% CO2 with or without an MOI of 0.001
IAVWSN. Virus or control inoculums were removed and cells incu-
bated for a further 2 days in 12 mL of OPTI-MEM supplemented
with Pen/Strep and 1.0 μg/mL trypsin-TPCK. After 48 h, the cells
were harvested, spun down, resuspended in 0.1 M glycine buffer
containing 0.9% NaCl, pH9.75 and shaken at 4°C for 20 min,
incubated in a sonication bath for 10 s intervals four times before
centrifugation at 2000 rpm for 20 min at 4°C. Supernatant was
aliquoted and frozen at −80°C.
Bone marrow DCs
BmDCs were prepared as described [52]. Briefly, bone mar-
row cells were flushed from the tibias and femurs of female
C57BL/6mice and RBCs removed. Cells were cultured in complete
RPMI (RPMI with 10% fetal calf serum, 100 μg/mL penicillin-
streptomycin, and 2 mM L-glutamine) at 37°C 5% CO2 in the
presence of GM-CSF (prepared from X-63 supernatant [53]) with
media supplemented on day 2 and replaced on day 5. On day
7, DCs were harvested, incubated overnight with either control
antigen or IAV antigen (MOI of 0.3).
Ex vivo restimulation
Single cell suspensions were cocultured with bmDCs in complete
RMPI at a ratio of approximately 10 T cells to 1 DC in the presence
of Golgi Plug (BD Bioscience, Franklin Lakes, NJ). Cocultures were
incubated at 37°C, 5% CO2 for 6 h unless stated. PI3K inhibitors
were used at: PI3K-δ, 100 nM; PI3K-γ, 300 nM. These concentra-
tions were selected as they are midrange for the concentrations
known to affect T-cell responses. All inhibitors were 300–1000-
fold selective over other PI3K family members.
Flow cytometry
Cells were harvested and following incubation with Fc block
(homemade containing 24G2 supernatant and mouse serum) sur-
face stained with anti-CD4 APC-Alexa 780 (eBioscience; clone:
RM4-5), anti-CD44 PerCP-Cy5.5 (eBioscience; clone: IM7), CD8
PeCy7 (eBioscience; clone: 53–6.7), and “dump” antibodies: B220
(clone: RA3-6B2) and MHC II (clone: M5114) both on eFluor-450
(eBioscience) for 20 min at 4°C. Cells were stained with a fixable
viability dye eFluor 506 (eBioscience) as per the manufacturer’s
recommendations. Cells were fixed with cytofix/cytoperm (BD
Bioscience) for 20 min at 4°C and stained in permwash buffer with
anticytokine antibodies for 1 h at room temperature (anti-IFN-γ PE
(clone: XMG1.2;), anti-TNF Alexa-Fluor-488 (clone: MP6-XT22),
anti-IL-2 APC (clone: JES6-5H4) all from eBioscience. Following
washing with permwash buffer, samples were acquired on a BD
LSR or Fortessa and analyzed using FlowJo (version 10 Treestar).
Data are presented as required for MIFlowCyt.
Statistical analysis
Data were analyzed using Prism version 7 software (GraphPad).
Differences between groups were analyzed by paired or unpaired
ANOVAs as indicated in figure legends. In all figures * represents
a p value of<0.05; **: p< 0.01, ***: p< 0.001, ****: p< 0.0001.
Acknowledgments: We thank the staff within the Institute of
Infection, Immunity and Inflammation Flow Cytometry Facility
and the Joint Research Facility at the University of Glasgow
for technical assistance. We thank Drs Georgia Perona-Wright,
Edward Hutchinson, and David Withers for critically reading the
manuscript. This work was supported by an Arthritis Research UK
Career Development Fellowship (19905) and a Marie Curie Fel-
lowship (334430) to MKLM, by a DTP-MRC studentship to JIG
(MR/JR50032X/1), and by the GLAZgo Discovery Centre.
Author contribution: LMW designed and performed experi-
ments, analyzed data and edited the manuscript. KM, LM, JIG,
C© 2019 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
2028 Lotus M Westerhof et al. Eur. J. Immunol. 2019. 49: 2019–2029
and AF performed experiments; MT provided reagents and edited
themanuscript; CSG designed research and edited themanuscript,
MKLM designed and performed the research, analyzed data and
wrote the manuscript.
Conflict of Interest: MT was an employee of AstraZeneca during
the study. CSG has received consulting fees from AstraZeneca
(more than $10,000). PI3K inhibitor tools were generated as
part of drug discovery projects aimed at modulating pulmonary
immune responses. Any subsequent commercial interests had no
influence on the design, performance, or interpretation of any
experiment presented in this body of work.
References
1 Harty, J. T., Tvinnereim, A. R. and White, D. W., CD8+ T cell effector
mechanisms in resistance to infection. Annu. Rev. Immunol. 2000. 18: 275–
308.
2 Jaigirdar, S. A. and MacLeod, M. K., Development and function of pro-
tective and pathologic memory CD4 T cells. Front. Immunol. 2015. 6: 456.
3 Yamane, H. and Paul, W. E., Early signaling events that underlie fate
decisions of naive CD4(+) T cells toward distinct T-helper cell subsets.
Immunol. Rev. 2013. 252: 12–23.
4 Iijima, N. and Iwasaki, A., Tissue instruction for migration and retention
of TRM cells. Trends Immunol. 2015. 36: 556–564.
5 Harrington, L. E., Janowski, K. M., Oliver, J. R., Zajac, A. J. andWeaver, C.
T., Memory CD4 T cells emerge from effector T-cell progenitors. Nature
2008. 452: 356–360.
6 Jacob, J. and Baltimore, D., Modelling T-cell memory by genetic marking
of memory T cells in vivo. Nature 1999. 399: 593–597.
7 Opferman, J. T., Ober, B. T. and Ashton-Rickardt, P. G., Linear differen-
tiation of cytotoxic effectors into memory T lymphocytes. Science 1999.
283: 1745–1748.
8 Swain, S. L., Agrewala, J. N., Brown, D. M., Jelley-Gibbs, D. M., Golech,
S., Huston, G., Jones S. C. et al., CD4+ T-cell memory: generation and
multi-faceted roles for CD4+ T cells in protective immunity to influenza.
Immunol. Rev. 2006. 211: 8–22.
9 Catron, D. M., Rusch, L. K., Hataye, J., Itano, A. A. and Jenkins, M. K.,
CD4+ T cells that enter the draining lymph nodes after antigen injection
participate in the primary response and become central-memory cells. J.
Exp. Med. 2006. 203: 1045–1054.
10 Jelley-Gibbs, D. M., Brown, D.M.,Dibble, J. P.,Haynes, L., Eaton, S. M. and
Swain, S. L., Unexpected prolonged presentation of influenza antigens
promotes CD4 T cell memory generation. J. Exp. Med. 2005. 202: 697–706.
11 Sarkar, S., Kalia, V., Haining, W. N., Konieczny, B. T., Subramaniam, S.
and Ahmed, R., Functional and genomic profiling of effector CD8 T cell
subsets with distinct memory fates. J. Exp. Med. 2008. 205: 625–640.
12 Almeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Born-
stein, E., Asher, T. E. et al., Superior control of HIV-1 replication by CD8+
T cells is reflected by their avidity, polyfunctionality, and clonal turnover.
J. Exp. Med. 2007. 204: 2473–2485.
13 Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W., Davey, D. F.,
Flynn, B. J.,Hoff S. T. et al., Multifunctional TH1 cells define a correlate of
vaccine-mediated protection against Leishmania major. Nat. Med. 2007.
13: 843–850.
14 Genesca, M., Rourke, T., Li, J., Bost, K., Chohan, B.,McChesney, M. B. and
Miller, C. J., Live attenuated lentivirus infection elicits polyfunctional
simian immunodeficiency virus Gag-specific CD8+ T cells with reduced
apoptotic susceptibility in rhesusmacaques that control virus replication
after challenge with pathogenic SIVmac239. J. Immunol. 2007. 179: 4732–
4740.
15 Lindenstrom, T.,Agger, E. M., Korsholm, K. S.,Darrah, P. A.,Aagaard, C.,
Seder, R. A., Rosenkrands, I. et al., Tuberculosis subunit vaccination pro-
vides long-term protective immunity characterized by multifunctional
CD4 memory T cells. J. Immunol. 2009. 182: 8047–8055.
16 MacLeod, M. K., Clambey, E. T., Kappler, J. W. and Marrack, P., CD4
memory T cells: what are they and what can they do? Semin. Immunol.
2009. 21: 53–61.
17 Macleod, M. K., David, A., Jin, N., Noges, L., Wang, J., Kappler, J. W. and
Marrack, P., Influenza nucleoprotein deliveredwith aluminium salts pro-
tects mice from an influenza A virus that expresses an altered nucleo-
protein sequence. PLoS One 2013. 8: e61775.
18 McKinstry, K. K., Strutt, T. M., Bautista, B., Zhang, W., Kuang, Y., Cooper,
A. M. and Swain, S. L., Effector CD4 T-cell transition to memory requires
late cognate interactions that induce autocrine IL-2. Nat. Commun. 2014.
5: 5377.
19 Strutt, T. M., McKinstry, K. K., Kuang, Y., Bradley, L. M. and Swain,
S. L., Memory CD4+ T-cell-mediated protection depends on secondary
effectors that are distinct from and superior to primary effectors. Proc.
Natl. Acad. Sci. USA 2012. 109: E2551–E2560.
20 Teijaro, J. R.,Turner, D., Pham, Q.,Wherry, E. J., Lefrancois, L. and Farber,
D. L., Cutting edge: tissue-retentive lung memory CD4 T cells mediate
optimal protection to respiratory virus infection. J. Immunol. 2011. 187:
5510–5514.
21 Nayak, J. L., Richards, K. A., Chaves, F. A. and Sant, A. J., Anal-
yses of the specificity of CD4 T cells during the primary immune
response to influenza virus reveals dramatic MHC-linked asymmetries
in reactivity to individual viral proteins. Viral Immunol. 2010. 23: 169–
180.
22 Richards, K. A., Chaves, F. A. and Sant, A. J., The memory phase of the
CD4 T-cell response to influenza virus infection maintains its diverse
antigen specificity. Immunology 2011. 133: 246–256.
23 Taylor, J. J. and Jenkins, M. K., CD4+ memory T-cell survival. Curr. Opin.
Immunol. 2011. 23: 319–323.
24 Mazo, I. B., Honczarenko, M., Leung, H., Cavanagh, L. L., Bonasio, R.,
Weninger, W., Engelke, K. et al., Bone marrow is a major reservoir and
site of recruitment for central memory CD8+ T cells. Immunity 2005. 22:
259–270.
25 Okhrimenko, A., Grun, J. R., Westendorf, K., Fang, Z., Reinke, S., von
Roth, P., Wassilew et al., Human memory T cells from the bone marrow
are resting and maintain long-lasting systemic memory. Proc. Natl. Acad.
Sci. USA 2014. 111: 9229–9234.
26 Reinhardt, R. L., Khoruts, A.,Merica, R., Zell, T. and Jenkins, M. K., Visu-
alizing the generation of memory CD4 T cells in the whole body. Nature
2001. 410: 101–105.
27 Sercan Alp, O., Durlanik, S., Schulz, D.,McGrath, M., Grun, J. R., Bardua,
M., Ikuta, K. et al., Memory CD8(+) T cells colocalize with IL-7(+) stromal
cells in bonemarrow and rest in terms of proliferation and transcription.
Eur. J. Immunol. 2015. 45: 975–987.
28 Teijaro, J. R., Verhoeven, D., Page, C. A., Turner, D. and Farber, D. L.,
Memory CD4 T cells direct protective responses to influenza virus in the
lungs through helper-independent mechanisms. J. Virol. 2010. 84: 9217–
9226.
29 Tokoyoda, K., Zehentmeier, S., Hegazy, A. N., Albrecht, I., Grun, J. R.,
Lohning,M. andRadbruch, A., ProfessionalmemoryCD4+ T lymphocytes
preferentially reside and rest in the bonemarrow. Immunity 2009. 30: 721–
730.
C© 2019 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
Eur. J. Immunol. 2019. 49: 2019–2029 Adaptive immunity 2029
30 Anderson, K. G.,Mayer-Barber, K., Sung, H., Beura, L., James, B. R., Tay-
lor, J. J., Qunaj, L. et al., Intravascular staining for discrimination of vas-
cular and tissue leukocytes. Nat. Protoc. 2014. 9: 209–222.
31 Mueller, S. N., Langley, W. A., Li, G., Garcia-Sastre, A., Webby, R. J. and
Ahmed, R., Qualitatively different memory CD8+ T cells are generated
after lymphocytic choriomeningitis virus and influenza virus infections.
J. Immunol. 2010. 185: 2182–2190.
32 Yang, C. Y., Best, J. A., Knell, J., Yang, E., Sheridan, A. D., Jesionek, A.
K., Li, H. S. et al., The transcriptional regulators Id2 and Id3 control the
formation of distinct memory CD8+ T cell subsets. Nat. Immunol. 2011.
12: 1221–1229.
33 Finlay, D. and Cantrell, D., The coordination of T-cell function by ser-
ine/threonine kinases. Cold Spring Harb Perspect. Biol. 2011. 3: a002261.
34 Han, J. M., Patterson, S. J. and Levings,M. K., The role of the PI3K signaling
pathway in CD4(+) T cell differentiation and function. Front. Immunol.
2012. 3: 245.
35 Khanolkar, A., Williams, M. A. and Harty, J. T., Antigen experience
shapes phenotype and function of memory Th1 cells. PLoS One 2013.
8: e65234.
36 Nelson, R. W., McLachlan, J. B., Kurtz, J. R. and Jenkins, M. K., CD4+
T cell persistence and function after infection are maintained by low-
level peptide: MHC class II presentation. J. Immunol. 2013. 190: 2828–
2834.
37 Miller, M. A., Ganesan, A. P., Luckashenak, N.,Mendonca, M. and Eisen-
lohr, L. C., Endogenous antigen processing drives the primary CD4+ T cell
response to influenza. Nat. Med. 2015. 21: 1216–1222.
38 Chandok, M. R., Okoye, F. I., Ndejembi, M. P. and Farber, D. L., A bio-
chemical signature for rapid recall of memory CD4 T cells. J. Immunol.
2007. 179: 3689–3698.
39 Watson, A. R. and Lee,W. T., Differences in signalingmolecule organiza-
tion between naive and memory CD4+ T lymphocytes. J. Immunol. 2004.
173: 33–41.
40 Berod, L.,Heinemann, C.,Heink, S., Escher, A., Stadelmann, C.,Drube, S.,
Wetzker, R. et al., PI3Kgamma deficiency delays the onset of experimen-
tal autoimmune encephalomyelitis and ameliorates its clinical outcome.
Eur. J. Immunol. 2011. 41: 833–844.
41 Ladygina, N., Gottipati, S., Ngo, K., Castro, G., Ma, J. Y., Banie, H.,
Rao T. S. et al., PI3Kgamma kinase activity is required for optimal
T-cell activation and differentiation. Eur. J. Immunol. 2013. 43: 3183–
3196.
42 Liu, D. and Uzonna, J. E., The p110 delta isoform of phosphatidylinositol
3-kinase controls the quality of secondary anti-Leishmania immunity by
regulating expansion and effector function of memory T cell subsets. J.
Immunol. 2010. 184: 3098–3105.
43 Okkenhaug, K., Patton, D. T., Bilancio, A., Garcon, F., Rowan, W. C. and
Vanhaesebroeck, B., The p110delta isoform of phosphoinositide 3-kinase
controls clonal expansion and differentiation of Th cells. J. Immunol. 2006.
177: 5122–5128.
44 Soond, D. R., Bjorgo, E., Moltu, K., Dale, V. Q., Patton, D. T., Torgersen,
K. M., Galleway, F. et al., PI3K p110delta regulates T-cell cytokine pro-
duction during primary and secondary immune responses in mice and
humans. Blood 2010. 115: 2203–2213.
45 Stark, A. K., Sriskantharajah, S., Hessel, E. M. and Okkenhaug, K., PI3K
inhibitors in inflammation, autoimmunity and cancer. Curr. Opin. Phar-
macol. 2015. 23: 82–91.
46 Britto, C. J., Brady, V., Lee, S. and Dela Cruz, C. S., Respiratory viral
infections in chronic lung diseases. Clin. Chest Med. 2017. 38: 87–96.
47 Bot, A., Bot, S. and Bona, C. A., Protective role of gamma interferon during
the recall response to influenza virus. J. Virol. 1998. 72: 6637–6645.
48 McMaster, S. R., Wilson, J. J., Wang, H. and Kohlmeier, J. E., Airway-
resident memory CD8 T cells provide antigen-specific protection against
respiratory virus challenge through rapid IFN-gamma production. J.
Immunol. 2015. 195: 203–209.
49 Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Car-
man,W., Bean, T. et al., Cellular immune correlates of protection against
symptomatic pandemic influenza. Nat. Med. 2013. 19: 1305–1312.
50 Wilkinson, T. M., Li, C. K.,Chui, C. S.,Huang, A. K., Perkins, M., Liebner, J.
C., Lambkin-Williams R. et al., Preexisting influenza-specific CD4+ T cells
correlate with disease protection against influenza challenge in humans.
Nat. Med. 2012. 18: 274–280.
51 Stuller, K. A., Cush, S. S. and Flano, E., Persistent gamma-herpesvirus
infection induces a CD4 T cell response containing functionally distinct
effector populations. J. Immunol. 2010. 184: 3850–3856.
52 Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S.,Mura-
matsu, S. and Steinman, R. M., Generation of large numbers of dendritic
cells from mouse bone marrow cultures supplemented with granulo-
cyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693–
1702.
53 Stoiber, D., Stockinger, S., Steinlein, P., Kovarik, J. and Decker, T., Liste-
ria monocytogenes modulates macrophage cytokine responses through
STAT serine phosphorylation and the induction of suppressor of cytokine
signaling 3. J. Immunol. 2001. 166: 466–472.
Abbreviations: bmDCs: bone marrow-derived dendritic cells · IAV:
influenza A virus · PI3K: PI3Kinases
Full correspondence: Dr. Megan KL MacLeod, Institute of Infection,
Immunity and Inflammation, University of Glasgow, B612, 120
University Place, Glasgow G128TA, United Kingdom of Great Britain
and Northern Ireland
e-mail: megan.macleod@glasgow.ac.uk
Current address: Kris McGuire, MRC Centre for Inflammation Research,
University of Edinburgh, Edinburgh, Scotland
Current address: Matthew Thomas, Exploratory Innovation
Department, Boehringer Ingelheim, Ingelheim am Rhein, Germany
The peer review history for this article is available at
https://publons.com/publon/10.1002/eji.201848026
Received: 22/11/2018
Revised: 29/4/2019
Accepted: 6/6/2019
Accepted article online: 8/6/2019
C© 2019 The Authors. European Journal of Immunology published by
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
www.eji-journal.eu
